An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Applied Medical Sciences | Volume-7 | Issue 09
Evaluation of Using High Resolution Computed Tomography in diagnosis of the Diffuse Parenchymal Lung Diseases
Ahmed Alsharef F Altom, Hussein Ahmed Hassan, Mogahid M A Zidan, Ala Mohammed Abd Elgyoum, Mona Elhaj, Hisham A.Y Gasmallah
Published: Sept. 30, 2019 | 73 75
DOI: 10.36347/sjams.2019.v07i09.044
Pages: 3138-3142
Downloads
Abstract
Introduction: High-resolution CT (HRCT) of the chest refers to a CT technique in which thin-slice chest images are obtained and post-processed in a high-spatial-frequency reconstruction algorithm. This technique obtains images with exquisite lung detail, which are ideal for the assessment of diffuse interstitial lung disease. The present study was undertaken to detectHRCT findings in diffuse parenchymal lung diseases and identifying the pattern, extent and distribution of the disease. Methodology: The present study comprised of 241 patients (143 males and 98 females) who underwent HRCT Chest with suspected diffuse parenchymal lung diseasesduring the period from June 2017 to September 2019 in CT departments of Alamal Diagnostic Center, Military hospital and Alyaa hospital-Omdurman. Results: The most commonly identified diffuseparenchymal lung disease was Nonspecific Interstitial Pneumonia (68) followed by Idiopathic pulmonary fibrosis (IPF)(65) and chronic bronchiectasis (53) of the total cases. Conclusion: HRCT is a simple non-invasive method for detecting diffuse parenchymal lung diseases. HRCT is of great value in patients with normal or questionable chest radiograph and with symptoms of diffuse parenchymal lung diseases. It has been concluded that High-resolution CT (HRCT) is the best modality for the evaluation of patients with diffuse pulmonary diseases because it provides detailed visualization of the lung parenchyma and identifying the pattern and distribution of disease helps in formulating a differential diagnosis, and detecting the diffuse parenchymal lung diseases in the early course of disease.